Ripasudil
Specifications
223645-67-8CAS Number
4-fluoro-5-[[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinolineIUPAC Name
C15H18FN3O2SChemical Formula
323.4 g/molMolecular Weight
Ripasudil; 223645-67-8; 4-fluoro-5-[[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline; K-321 anhydrous free base; 11978226XX; DTXSID001025609; 1H-1,4-Diazepine, 1-((4-fluoro-5-isoquinolinyl)sulfonyl)hexahydro-2-methyl-, (2S)-; Isoquinoline, 4-fluoro-5-(((2S)-hexahydro-2-methyl-1H-1,4-diazepin-1-yl)sulfonyl)-; ripasudilum; 4-fluoro-5-(((2S)-2-methyl-1,4-diazepan-1-yl)sulfonyl)isoquinoline; 1H-1,4-Diazepine, 1-[(4-fluoro-5-isoquinolinyl)sulfonyl]hexahydro-2-methyl-, (2S)-; Isoquinoline, 4-fluoro-5-[[(2S)-hexahydro-2-methyl-1H-1,4-diazepin-1-yl]sulfonyl]-; RefChem:179484; DTXCID001509873; K-115 free base; k115 Free base; Ripasudil free base; Ripasudil [INN]; (S)-4-Fluoro-5-((2-methyl-1,4-diazepan-1-yl)sulfonyl)isoquinoline; CHEMBL3426621; UNII-11978226XX; RIPASUDIL [MI]; Ripasudil (USAN/INN); RIPASUDIL [USAN]; RIPASUDIL [WHO-DD]; K-115 anhydrous free base; SCHEMBL31542; C15H18FN3O2S; orb1220330; orb1685487; SCHEMBL29356679; GTPL10423; CHEBI:136046; EX-A3647; BDBM50087135; HY-15685A; MFCD28291829; NSC800869; AKOS027338679; CS-3402; DB13165; EBC-237024; NSC-800869; NCGC00496843-01; AC-36873; AS-35170; K-115 (ripasudil hydrochloride dihydrate); NS00069625; T7492; D13014; BRD-K53814070-310-01-3; Q21098890; (S)-(-)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine; 4-Fluoro-5-[[(2S)-hexahydro-2-methyl-1H-1,4-diazepin-1-yl]sulfonyl]isoquinolineSynonyms
